AU Patent

AU735460B2 — Uses of a chemokine receptor for inhibiting HIV-1 infection

Assigned to Progenics Pharmaceuticals Inc · Expires 2001-07-12 · 25y expired

What this patent protects

Patent listed against Vyndaqel.

Drugs covered by this patent

Patent Metadata

Patent number
AU735460B2
Jurisdiction
AU
Classification
—
Expires
2001-07-12
Drug substance claim
No
Drug product claim
No
Assignee
Progenics Pharmaceuticals Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.